CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in CollPlant Biotechnologies Ltd as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +4 vs. Q1 2022
- Shares held
- 1.74M
- +16.8K (+1.0%) vs. Q1 2022
- Total value
- $14.3M
- −$5.14M (−26.4%) vs. Q1 2022
- New holders
- 7
- 4 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 50 | $0 | 0.00% | −200−80.0% | Reduced |
| First Manhattan Co | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Venture Visionary Partners LLC | 115 | $920 | 0.00% | +115 | New |
| Geneos Wealth Management Inc. | 750 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 892 | $7.00K | 0.00% | +892 | New |
| Cohanzick Management, LLC | 2,000 | $16.0K | 0.00% | +2,000 | New |
| The PNC Financial Services Group, Inc. | 3,600 | $28.0K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 5,000 | $40.0K | 0.03% | 00.0% | Unchanged |
| UBS Group AG | 7,514 | $60.0K | 0.00% | +4,085+119.1% | Added |
| Private Advisor Group, LLC | 12,862 | $103.0K | 0.00% | +12,862 | New |
| Parallel Advisors, LLC | 16,382 | $131.0K | 0.01% | 00.0% | Unchanged |
| Simon Quick Advisors, LLC | 15,676 | $139.0K | 0.02% | +15,676 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,210 | $189.0K | 0.00% | +23,210 | New |
| LPL Financial LLC | 45,070 | $361.0K | 0.00% | +45,070 | New |
| Benjamin F. Edwards & Company, Inc. | 71,810 | $585.0K | 0.03% | −3,460−4.6% | Reduced |
| Brown Advisory Inc | 77,349 | $619.0K | 0.00% | 00.0% | Unchanged |
| Villere St Denis J & Co LLC | 266,897 | $2.13M | 0.16% | +900+0.3% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 235,660 | $2.19M | 0.01% | +7,003+3.1% | Added |
| Investment Management of Virginia LLC | 346,533 | $2.77M | 0.57% | −97,911−22.0% | Reduced |
| Roumell Asset Management, LLC | 605,437 | $4.93M | 9.60% | +7,775+1.3% | Added |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −825−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −248−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −100−100.0% | Sold out |